Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Science 37 Holdings, Inc. SNCE
$0.23
-$0.02 (-7.09%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
32182185.00000000
-
week52high
4.31
-
week52low
0.19
-
Revenue
70147000
-
P/E TTM
-6
-
Beta
1.32611900
-
EPS
-0.44000000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 мая 2023 г. в 12:30
Описание компании
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Craig-Hallum | Buy | 07 июн 2022 г. | |
| William Blair | Outperform | 01 ноя 2021 г. | |
| Lake Street | Buy | 01 ноя 2021 г. | |
| Baird | Outperform | 01 ноя 2021 г. | |
| Cowen & Co. | Outperform | 22 окт 2021 г. | |
| William Blair | Market Perform | Outperform | 14 ноя 2022 г. |
| Cowen & Co. | Outperform | Outperform | 14 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Pellizzari Christine A | A | 5000 | 5000 | 17 ноя 2022 г. |
| von Autenried Paul | A | 46040 | 46040 | 07 окт 2022 г. |
| Shipton Michael | A | 300000 | 300000 | 07 окт 2022 г. |
| Geffon Steven | A | 563414 | 563414 | 12 авг 2022 г. |
| Cotliar Jonathan | A | 692646 | 692646 | 12 авг 2022 г. |
| Forman Darcy | A | 866914 | 866914 | 12 авг 2022 г. |
| Coman David | A | 1485365 | 1485365 | 12 авг 2022 г. |
| Pellizzari Christine A | A | 1066646 | 1066646 | 12 авг 2022 г. |
| Zaranek Mike | A | 768621 | 768621 | 12 авг 2022 г. |
| Forman Darcy | D | 68075 | 68075 | 29 июн 2022 г. |
Новостная лента
Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference
GlobeNewsWire
30 ноя 2022 г. в 16:05
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today announced the company will be participating in the upcoming 5th Annual Evercore ISI HealthCONx Conference.
Science 37 Holdings, Inc. (SNCE) Q3 2022 Earnings Call Transcript
Seeking Alpha
11 ноя 2022 г. в 13:14
Start Time: 08:30 January 1, 0000 9:07 AM ET Science 37 Holdings, Inc. (NASDAQ:SNCE ) Q3 2022 Earnings Conference Call November 11, 2022, 08:30 AM ET Company Participants David Coman - CEO Mike Zaranek - CFO Steve Halper - Managing Director, LifeSci Advisors Conference Call Participants Steven Braun - Cowen Max Smock - William Blair Matthew Hewitt - Craig-Hallum Frank Takkinen - Lake Street Eric Coldwell - Baird David Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Science 37 Third Quarter 2022 Earnings Conference Call.
Science 37 Holdings, Inc. (SNCE) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 18:48
Science 37 Holdings, Inc. (SNCE) delivered earnings and revenue surprises of 5.88% and 21.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022
GlobeNewsWire
01 ноя 2022 г. в 07:55
RESEARCH TRIANGLE PARK, N.C., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™ today announced it will report third quarter 2022 financial results after the market closes on Thursday, November 10, 2022. Company management will host a corresponding conference call on Friday, November 11, 2022, at 8:30 a.m. Eastern Time.
Science 37 to Present at the Baird 2022 Global Healthcare Conference
GlobeNewsWire
08 сент 2022 г. в 16:01
RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Science 37® Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Baird Global Healthcare Conference in New York.